Abdullah Kutlar

Dr. Abdullah Kutlar is a distinguished Professor of Medicine and the esteemed Director of the Sickle Cell Center at the Medical College of Georgia, Augusta University. A graduate of Ankara University Medical School in Turkey, Dr. Kutlar further honed his expertise by completing his residency and fellowship in internal medicine and hematology at Istanbul University Medical School. His academic journey and professional dedication have been pivotal in shaping his career, leading to his long-standing association with the Medical College of Georgia since 1992. Dr. Kutlar is renowned for his extensive research in sickle cell disease and hemoglobinopathies, areas in which he has made significant contributions. His work has garnered substantial research support, exceeding nine million dollars, underscoring the impact and importance of his research endeavors. His prolific output includes over 200 original articles, reflecting his commitment to advancing knowledge and treatment in his field. As an active member of the American Society of Hematology, Dr. Kutlar is deeply involved in the broader hematology community, contributing to the advancement of research and clinical practices. His leadership at the Sickle Cell Center has been instrumental in securing continuous funding from the State of Georgia, ensuring the center's role as the State's confirmation lab for suspected hemoglobinopathies identified through newborn screening. Under Dr. Kutlar's direction, the Sickle Cell Center has become a beacon of research and clinical excellence, providing critical services and support for individuals affected by sickle cell disease and related disorders. His dedication to his field is evident in his ongoing efforts to improve patient outcomes and enhance the understanding of hemoglobinopathies. Dr. Kutlar's career is marked by a commitment to education, research, and clinical excellence, making him a respected figure in the medical community. His contributions continue to influence the field of hematology, benefiting both patients and fellow researchers alike.